Recent studies support our conclusion that a global loss of CTCF binding explains the global increase in open chromatin observed in ATRX-deficient human and murine gliomas (Fig. 2C and 4H) and point to a mechanism by which these differences regulate gene expression. Here, CTCF is linked to central nervous system cancer.